There are significant questions on how the order can be implemented, and if companies can raise prices on already approved drugs, analysts say.

Pfizer (PFE), and Eli Lilly (LLY) traded in the green Monday morning despite declining in pre-market hours after President Donald Trump signed a new executive order that will push drugmakers to sell ...

Eli Lilly (NYSE:LLY ... The latest executive order on drug prices by President Donald Trump has only added to its woes, or has it? The order signed on May 12 aims to align U.S. drug prices ...

The U.S. imports more pharmaceutical products from Ireland than from any other country -- nearly $50 billion last year. It won't be surprising if the Trump administration especially targets those ...

In an executive order Monday morning, Trump announced plans to reduce drug prices by 30 to 80%.

The president said his executive order will require pharmaceutical companies to price drugs in the U.S. in line with the ...

US President Donald Trump has signed an executive order that aims to reduce high prescription drug prices – but its details ...

LONDON (Reuters) -U.S. President Donald Trump's executive order on drug pricing threatens Roche's planned $50 billion investment in the United States, the company said on Wednesday.

Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will ...

Evernorth said that through direct negotiations with Novo Nordisk and Eli Lilly, patients’ monthly copay costs for Wegovy ...

Drugmakers are offering the blockbuster medications at steep discounts to people willing to pay out of pocket.

Trump's order seeks to ease regulations to compel more U.S. drug manufacturing. He also plans to assess tariffs on drug ...